Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia - PubMed (original) (raw)
. 2002 Jul 1;100(1):67-71.
doi: 10.1182/blood.v100.1.67.
Affiliations
- PMID: 12070010
- DOI: 10.1182/blood.v100.1.67
Free article
Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia
Stella M Davies et al. Blood. 2002.
Free article
Abstract
The glutathione S-transferase (GST) genes are involved in the metabolism of environmental carcinogens and of some classes of chemotherapy drugs. GSTM1 and GSTT1 genotypes are polymorphic in humans, and the phenotypic absence of enzyme activity is caused by a homozygous inherited deletion of the gene. Previous, smaller studies of childhood acute lymphoblastic leukemia (ALL) provided contrasting data on the role of the GST genotype in susceptibility and treatment outcomes. We analyzed GST genotypes in 710 children with ALL treated by the Children's Cancer Group. Frequencies were compared with those of normal controls, and outcomes were analyzed according to genotype. Comparisons of gene frequencies in ALL case and control patients showed similar frequencies (54% vs 53% GSTM1 null in whites, P =.9; 40% versus 32% in blacks, P =.45; 16% versus 15% GSTT1 null in whites, P =.8; 17% versus 28% in blacks, P =.3). ALL was not associated with the GSTM1-null genotype or the double-null genotype in blacks or whites, in contrast to previous reports. Stratification of cases by age at diagnosis, sex, white blood cell count at diagnosis, B or T lineage, or cytogenetics revealed no differences in genotype frequencies. Analysis of treatment outcomes showed no differences in outcome according to GST genotype; in particular, there were no differences in frequencies of relapse at any site. These data, representing a larger series than any reported previously, suggest that GST genotype does not affect etiology or outcome of childhood ALL.
Similar articles
- Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia.
Chen CL, Liu Q, Pui CH, Rivera GK, Sandlund JT, Ribeiro R, Evans WE, Relling MV. Chen CL, et al. Blood. 1997 Mar 1;89(5):1701-7. Blood. 1997. PMID: 9057653 - Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
Takanashi M, Morimoto A, Yagi T, Kuriyama K, Kano G, Imamura T, Hibi S, Todo S, Imashuku S. Takanashi M, et al. Haematologica. 2003 Nov;88(11):1238-44. Haematologica. 2003. PMID: 14607752 - [Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia].
Gra OA, Glotov AS, Kozhekbaeva Zhm, Makarova OV, Nasedkina TV. Gra OA, et al. Mol Biol (Mosk). 2008 Mar-Apr;42(2):214-25. Mol Biol (Mosk). 2008. PMID: 18610829 Russian. - [Study on the relationship between polymorphisms of Cyp1A1, GSTM1, GSTT1 genes and the susceptibility to acute leukemia in the general population of Hunan province].
Liu QX, Chen HC, Liu XF, Cao YF, Zhang J, Liu J. Liu QX, et al. Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Dec;26(12):975-9. Zhonghua Liu Xing Bing Xue Za Zhi. 2005. PMID: 16676594 Chinese. - Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis.
Ye Z, Song H. Ye Z, et al. Eur J Cancer. 2005 May;41(7):980-9. doi: 10.1016/j.ejca.2005.01.014. Eur J Cancer. 2005. PMID: 15862746 Review.
Cited by
- Association Between the Individual and Combined Effects of the GSTM1 and GSTT1 Polymorphisms and Risk of Leukemia: A Meta-Analysis.
Hu T, Zhou G, Li W. Hu T, et al. Front Genet. 2022 Jul 22;13:898937. doi: 10.3389/fgene.2022.898937. eCollection 2022. Front Genet. 2022. PMID: 35938012 Free PMC article. - Increased Risk of Acute Lymphoblastic Leukemia in Adult Patients with GSTM1 Null Genetic Polymorphism.
Abdalhabib EK, Alzahrani B, Alanazi F, Algarni A, Ibrahim IK, Mohamed HA, Hamali HA, Mobarki AA, Dobie G, Saboor M. Abdalhabib EK, et al. Pharmgenomics Pers Med. 2022 Mar 15;15:227-234. doi: 10.2147/PGPM.S356302. eCollection 2022. Pharmgenomics Pers Med. 2022. PMID: 35313604 Free PMC article. - GSTT1 null and rs156697 Polymorphism in GSTO2 Influence the Risk and Therapeutic Outcome of B-Acute Lymphoblastic Leukemia Patients.
Baba SM, Pandith AA, Shah ZA, Geelani SA, Bhat JR, Gul A, Guru SA, El-Serehy HA, Koul AM, Mansoor S. Baba SM, et al. Front Oncol. 2021 Oct 14;11:714421. doi: 10.3389/fonc.2021.714421. eCollection 2021. Front Oncol. 2021. PMID: 34722260 Free PMC article. - Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity.
Yang X, Li G, Yang T, Guan M, An N, Yang F, Dai Q, Zhong C, Luo C, Gao Y, Das S, Xing Y, Shang H. Yang X, et al. Oxid Med Cell Longev. 2020 Oct 13;2020:4894625. doi: 10.1155/2020/4894625. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 33110473 Free PMC article. Review. - Role of glutathione S-transferase M1, T1 and P1 gene polymorphisms in childhood acute lymphoblastic leukemia susceptibility in a Turkish population.
Guven M, Unal S, Erhan D, Ozdemir N, Baris S, Celkan T, Bostancı M, Batar B. Guven M, et al. Meta Gene. 2015 Jun 17;5:115-9. doi: 10.1016/j.mgene.2015.06.002. eCollection 2015 Sep. Meta Gene. 2015. PMID: 26137447 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- 5U10-CA 13539/CA/NCI NIH HHS/United States
- CA02649/CA/NCI NIH HHS/United States
- CA02971/CA/NCI NIH HHS/United States
- CA03526/CA/NCI NIH HHS/United States
- CA03750/CA/NCI NIH HHS/United States
- CA03888/CA/NCI NIH HHS/United States
- CA05436/CA/NCI NIH HHS/United States
- CA07306/CA/NCI NIH HHS/United States
- CA07431/CA/NCI NIH HHS/United States
- CA10198/CA/NCI NIH HHS/United States
- CA10382/CA/NCI NIH HHS/United States
- CA11174/CA/NCI NIH HHS/United States
- CA13539/CA/NCI NIH HHS/United States
- CA13809/CA/NCI NIH HHS/United States
- CA14560/CA/NCI NIH HHS/United States
- CA17829/CA/NCI NIH HHS/United States
- CA20320/CA/NCI NIH HHS/United States
- CA26044/CA/NCI NIH HHS/United States
- CA26126/CA/NCI NIH HHS/United States
- CA26270/CA/NCI NIH HHS/United States
- CA27678/CA/NCI NIH HHS/United States
- CA28851/CA/NCI NIH HHS/United States
- CA28882/CA/NCI NIH HHS/United States
- CA29013/CA/NCI NIH HHS/United States
- CA29314/CA/NCI NIH HHS/United States
- CA36004/CA/NCI NIH HHS/United States
- CA36015/CA/NCI NIH HHS/United States
- CA42764/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous